Vestibular schwannoma: Role of conservative management

Journal of Laryngology and Otology

Volumn 124, Issue 3, 2010, Pages 251-257

  Suryanarayanan, R ^a   Ramsden, R T ^a   Saeed, S R ^b   Aggarwal, R ^a   King, A T ^a   Rutherford, S A ^a   Evans, D G ^a   Gillespie, J E ^a  

^a MANCHESTER ROYAL INFIRMARY   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Follow up studies; Magnetic resonance imaging; Neurofibromatosis 2; Neuroma, acoustic

Indexed keywords

ACOUSTIC NEURINOMA; ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CONSERVATIVE TREATMENT; FEMALE; FOLLOW UP; HUMAN; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; NEURILEMOMA; NEUROFIBROMATOSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; TUMOR GROWTH; TUMOR VOLUME; WATCHFUL WAITING;

ADULT; AGED; AGED, 80 AND OVER; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEUROFIBROMATOSIS 2; NEUROMA, ACOUSTIC; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME; TUMOR BURDEN; YOUNG ADULT;

EID: 77949575189     PISSN: 00222151     EISSN: 17485460     Source Type: Journal    
DOI: 10.1017/S0022215109992362     Document Type: Article

References (26)

1. Kanzaki J, Tos M, Sanna M. New and modified reporting systems from the consensus meeting on systems for reporting results in Vestibular Schwannoma. Otol Neurotol 2003; 24:642-649
2. Nikolopoulos TP, O'Donoghue GM. Acoustic neuroma management: an evidence-based medicine approach. Otol Neurotol 2002;23:534-541
3. Yoshimoto Y. Systematic review of the natural history of vestibular schwannoma. J Neurosurg 2005;103:59-63
4. Suryanarayanan R, Lesser THJ. Growth rate of vestibular schwannoma-what the literature tells us. The Otorhinolaryngologist 2007;1:66-71
5. Selesnick HS, Johnson G. Radiologic surveillance of acoustic neuromas. Am J Otol 1998;19:846-849
6. Smouha EE, Yoo M, Mohr K, Davis RP. Conservative management of acoustic neuroma: a meta-analysis and proposed treatment algorithm. Laryngoscope 2005;115:450-454
7. Yamakami I, Uchino Y, Kobayashi E, YamauraA. Conservative management, gamma-knife radiosurgery and microsurgery for acoustic neurinomas: a systematic review of outcome and risk of three therapeutic options. Neurol Res 2003;25:682-690
8. Baser ME, Mautner VF, Parry DM, Evans DGR. Methodological issues in longitudinal studies: vestibular schwannoma growth rates in neurofibromatosis 2. J Med Genet 2005;42:903-906
9. Ogawa K, Kanzaki J, Ogawa S, Yamamoto M, Ikeda S, Shiobara R. The growth rate of acoustic neuromas. Acta Otolaryngol Suppl 1991;487:157-163
10. Charabi S, Thomsen J, Tos M, Charabi B, Mantoni M, Borgesen SE.Acoustic neuroma/vestibular schwannomagrowth: past, present and future. Acta Otolaryngol 1998;118:327-332
11. Niemczyk K, Vaneecloo FM, Lemaitre L, Lejeune JP, Skarzynski H, Dubrulle F. The growth of acoustic neuromas in volumetric radiologic assessment. Am J Otol 1999; 20:244-248
12. Laasonen E, Troupp H. Volume growth rate of acoustic neurinomas. Neuroradiology 1986;28:203-207
13. Valvassori GE, Guzman M. Growth rate of acoustic neuromas. Am J Otol 1989;10:174-176
14. Mirz F, Jorgensen B, Fiirgaard B, Lundorf E, Pedersen CB. Investigations into the natural history of vestibular schwannomas. Clin Otol 1999;24:13-18
15. Fucci MJ, Buchman CA, Brackmann DE, Berliner KI. Acoustic tumour growth: implications for treatment choices. Am J Otol 1999;20:495-499
16. Martin TPC, Tzifa K, Kowalski C, Holder RL, Walsh R, Irving RM. Conservative versus primary surgical treatment of acoustic neuromas: a comparison of rates of facial nerve and hearing preservation. Clin Otolaryngol 2008;33:228-235
17. Walsh RM, Bath AP, Bance ML, Keller A, Tator CH, Rutka JA. The role of conservative management of vestibular schwannomas. Clin Otolaryngol 2000;25:28-39
18. Charabi S, Thomsen J, Mantoni M, Charabi B, Jorgensen B, Borgesen SE. Acoustic neuroma: growth and surgical and nonsurgical consequences of the wait and see policy. Otolaryngol Head Neck Surg 1995;113:5-14
19. TschudiDC, LinderTE, Fisch U.Conservative management of unilateral acoustic neuromas. Am J Otol 2000;21:722-728
20. Deen HG, Ebersold MJ, Harner SG, Beatty CW, Marion MS, Wharen RE. Conservative management of acoustic neuroma: an outcome study. Neurosurgery 1996; 39:260-264
21. O'Reilly B, Murray CD, Hadley DM. The conservative management of acoustic neuroma: a review of forty-four patients with magnetic resonance imaging. Clin Otolaryngol 2000;25:93-97
22. Herwadker A, Vokurka EA, Evans DGR, Ramsden RT, Jackson A. Size and growth rate of sporadic vestibular schwannoma: predictive value of information available at presentation. Otol Neurotol 2005;26:86-92
23. Mohyuddin A, Vokurka EA, Evans DG, Ramsden RT, Jackson A. Is clinical growth index a reliable predictor of tumor growth in vestibular schwannomas? Clin Otolaryngol 2003;28:85-90
24. Rosenberg SI. Natural history of acoustic neuromas. Laryngoscope 2000;110:497-508
25. Evans DG, Trueman L, Wallace A, Collins S, Strachan T. Genotype/phenotype correlations in type 2 neurofibromatosis (NF2): evidence for more severe disease associated with truncating mutations. J Med Genet 1998;35:450-455
26. Baser ME, Kuramoto L, Joe H, Friedman JM, Wallace AJ, Gillespie JE et al. Genotype-phenotype correlations for nervous system tumors in neurofibromatosis 2: a populationbased study. Am J Hum Genet 2004;75:231-239